as 12-20-2024 4:00pm EST
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
Founded: | 2020 | Country: | United States |
Employees: | N/A | City: | NEW YORK |
Market Cap: | 3.1M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 4.4M |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -3.26 | EPS Growth: | N/A |
52 Week Low/High: | $0.22 - $2.27 | Next Earning Date: | 11-13-2024 |
Revenue: | $4,022,389 | Revenue Growth: | -42.41% |
Revenue Growth (this year): | -4.8% | Revenue Growth (next year): | 0.76% |
PTPI Breaking Stock News: Dive into PTPI Ticker-Specific Updates for Smart Investing
ACCESSWIRE
3 days ago
ACCESSWIRE
5 days ago
Simply Wall St.
a month ago
TipRanks
2 months ago
ACCESSWIRE
3 months ago
ACCESSWIRE
4 months ago
Simply Wall St.
4 months ago
ACCESSWIRE
5 months ago
The information presented on this page, "PTPI Petros Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.